We use cookies to distinguish you from other users and to provide you with a better experience on our websites. Close this message to accept cookies or find out how to manage your cookie settings.
An abstract is not available for this content so a preview has been provided. As you have access to this content, a full PDF is available via the ‘Save PDF’ action button.
Bottaï, T., Petit, P., Pinzani, V., et al (1992) Neuroleptic malignant syndrome: 11 case reports. 18th Collegium Internationale Neuropsychopharmacologicum. Clinical Neuropharmacology, 15 (suppl. 1), 138B.Google Scholar
DasGupta, K. & Young, A. (1991) Clozapine-induced neuroleptic malignant syndrome. Journal of Clinical Psychiatry, 52, 105–107.Google ScholarPubMed
Miller, D. D., Sharafuddin, M. J. & Kathol, R. G. (1991) A case of clozapine-induced neuroleptic malignant syndrome. Journal of Clinical Psychiatry, 52, 99–101.Google ScholarPubMed
Pope, H. G., Aizley, H. G., Keck, P. E., et al (1991) Neuroleptic malignant syndrome: long-term follow-up of 20 cases. Journal of Clinical Psychiatry, 52, 208–212.Google Scholar
Stephens, M. D. B. (1988) Drug rechallenge. In The Detection of New Adverse Drug Reactions (ed. Stephen, M. D. B.), pp. 201–209. London: The Macmillan Press.CrossRefGoogle Scholar
eLetters
No eLetters have been published for this article.